I-Mab（股票代码：IMAB）今日盘前大涨5.70%，引起投资者广泛关注。
消息面上，I-Mab于今日早间宣布任命资深生物技术高管加入公司董事会和科学顾问委员会，同时成立研发委员会。这一系列人事变动被市场视为公司加强研发实力和公司治理的积极信号，从而推动了股价的上涨。
具体而言，I-Mab新任命的高管们拥有丰富的生物技术行业经验，他们的加入有望为公司带来新的视角和专业知识。特别是成立研发委员会的举措，表明公司正在加大对研发的重视和投入，这可能会增强I-Mab在生物制药领域的竞争力。投资者对这一战略调整反应积极，期待这些变革能够推动公司未来的创新和增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.